Purification and characterization of human-derived Pneumocystis jirovecii dihydrofolate reductase expressed in Sf21 insect cells and in Escherichia coli

Protein Expression and Purification

Volumn 40, Issue 2, 2005, Pages 417-423

  Cody, Vivian ^a   Chisum, Kim ^a   Pope, Carleen ^a   Queener, Sherry F ^b  

^a HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Antifolate inhibitors; Baculovirus; Recombinant hpDHFR

Indexed keywords

EID: 14844337916     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2004.12.028     Document Type: Article

References (17)

1. J.R. Stringer, C.B. Beard, R.F. Miller, and A.E. Wakefield A new name (Pneumocystis jirovecii) for Pneumocystis from humans Emerg. Infect. Dis. 8 2002 891 896
2. J.A. Kovacs, J.R. Hiemenz, A.M. Macher, D. Stover, H.W. Murray, J. Shelhamer, H.C. Lane, C. Urmacher, C. Honig, D.L. Longo, M.M. Parker, C. Natanson, J.E. Parrillo, A.S. Fauci, P.A. Pizzo, and H. Masur Pneumocystis carinii pneumonia: A comparison between patients with acquired immunodeficiency syndrome and patients with other immunodeficiencies Ann. Intern. Med. 100 1984 663 671
3. J.A. Kovacs, and H. Masur Pneumocystis carinii pneumonia: Therapy and prophylaxis J. Infect. Dis. 158 1988 254 259
4. S.P. Keely, J.R. Stringer, R.P. Baughman, M.J. Linke, P.D. Walzer, and A.G. Smulian Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis J. Infect. Dis. 172 1995 595 598
5. L. Ma, L. Borio, H. Masur, and J.A. Kovacs Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior Trimethoprim-Sulfamethoxazole or Dapsone use J. Infect. Dis. 180 1999 1969 1978
6. L. Ma, J.A. Kovacs, A. Cargnel, A. Valerio, G. Fantoni, and C. Atzori Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis J. Infect. Dis. 185 2002 1530 1532
7. C.B. Beard, J.L. Carter, S.P. Keely, L. Huang, N.J. Pienazek, I.N.S. Moura, J.M. Roberts, A.W. Hightower, M.S. Bens, A.R. Freeman, S. Lee, J.R. Stringer, J.S. Duchin, C. del Rio, D. Rimland, R.P. Baughman, D.A. Levy, V.J. Dietz, P. Simon, and T.R. Navin Genetic variation in Pneumocystis carinii isolates from different geographic regions: Implications for transmission Emerg. Infect. Dis. 6 2000 265 272
8. T. Takahashi, T. Kanada, and A. Iwamoto Genetic diversity of drug targets including dihydropteroate synthase, dihydrofolate reductase and cytochrome b, in Pneumocystis carinii f. sp. hominis isolates in Japan Res. Commun. Mol. Pathol. Pharmacol. 112 2002 159 176
9. L. Ma, H. Imamichi, A. Sukura, and J.A. Kovacs Genetic divergence of the dihydrofolate reductase and dihydropteroate synthase genes in Pneumocystis carinii from seven different host species J. Infect. Dis. 184 2001 1358 1362
10. C.J. Delves, S.P. Ballantine, R.L. Tansik, D.P. Baccanari, and D.K. Stammers Refolding of recombinant Pneumocystis carinii dihydrofolate reductase and characterization of the enzyme Protein Expr. Purif. 4 1993 16 23
11. M.C. Broughton, and S.F. Queener Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs Antimicrob. Agents Chemother. 35 1991 1348 1355
12. E. Sloand, B. Laughon, M. Armstrong, M.S. Bartlett, W. Blumenfeld, M. Cushion, A. Kalica, J.A. Kovacs, W. Martin, and E. Pitt The challenge of Pneumocystis carinii culture J. Eukaryot. Microbiol. 40 1993 188 195
13. L. Ma, and J.A. Kovacs Expression and characterization of recombinant human-derived Pneumocystis carinii dihydrofolate reductase Antimicrob. Agents Chemother. 44 2000 3092 3096
14. A. Gangjee, O.O. Adair, and S.F. Queener Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents J. Med. Chem. 46 2003 5074 5082
15. A. Rosowsky, R.A. Forsch, and S.F. Queener Further studies on 2,4-diamino-5-(2′,5′-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS J. Med. Chem. 46 2003 1726 1736
16. Y. Wang, J. Bruenn, S.F. Queener, and V. Cody Isolation of rat dihydrofolate reductase gene and characterization of the recombinant enzyme Antimicrob. Agents Chemother. 45 2001 2517 2523
17. V. Cody, J.B. Pace, K. Chisum, and A. Rosowsky The role of flexibility in drug design: Structure determination of Pneumocystis carinii dihydrofolate reductase complex with a potent 4-carboxybutyl Trimethoprim derivative Am. Assoc. Cancer Res. Proc. 45 2004 427